• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Elucidation of gene polymorphisms related with adverse events in the treatment of childhood acute lymphoblastic leukemia

Research Project

Project/Area Number 17K10129
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Pediatrics
Research InstitutionHokkaido University (2019)
St. Luke's International University (2017-2018)

Principal Investigator

Manabe Atsushi  北海道大学, 医学研究院, 教授 (20292849)

Co-Investigator(Kenkyū-buntansha) 田中 庸一  北里大学, 薬学部, 講師 (40525341)
浦山 ケビン  聖路加国際大学, 専門職大学院公衆衛生学研究科(公衆衛生大学院), 教授 (60726850)
Project Period (FY) 2017-04-01 – 2020-03-31
Project Status Completed (Fiscal Year 2019)
Budget Amount *help
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2019: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2018: ¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
Fiscal Year 2017: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Keywords小児 / 白血病 / 治療毒性 / 遺伝子多型 / 薬理ゲノム学 / ゲノム薬理学 / 小児腫瘍学
Outline of Final Research Achievements

Acute lymphoblastic leukemia (ALL) is the most common childhood cancer and long-term survival is expected in roughly 80% of patients. However, treatment-related toxicity is still a problem. We conducted a pharmacogenomic study in children with ALL. As a result, MTHFR gene polymorphism was related with clearance of methotrexate (MTX) in high-dose MTX treatment (n=79) among 5 genes (SLCO1B1, SLC19A1, ABCB1, ABCC2, ABCG2, and MTHFR). The most relevant gene polymorphism related with hematotoxicity of 6-mercaptopurine was NUDT15 (n=239), but not TPMT, which was strongly correlated in Caucasians. The result was validated using another cohort of patients (n=55). The difference in ethnicity should be considered to interpret the pharmacogenomic data.

Academic Significance and Societal Importance of the Research Achievements

急性リンパ性白血病(ALL)は最も頻度の高い小児がんである。ALLの治療成績の改善はめざましく、約80%に長期生存が期待できるが、化学療法に伴う治療毒性は大きな問題である。近年のゲノム薬理学の進歩により、治療毒性に関わる遺伝子変異が同定されてきたが、人種による差異が大きい。本研究の結果、MTHFR遺伝子多型とメソトレキサートのクリアランスとの間に相関がみられた。また6-メルカプトプリンの血液毒性では、白人で意味のあるTPMT多型は有意でなく、NUDT15多型は有意であった。薬剤による有害事象は人種差が大きいため、日本人を対象にした遺伝子多型の検討は重要である。

Report

(4 results)
  • 2019 Annual Research Report   Final Research Report ( PDF )
  • 2018 Research-status Report
  • 2017 Research-status Report
  • Research Products

    (15 results)

All 2019 2018 2017 Other

All Int'l Joint Research (2 results) Journal Article (9 results) (of which Int'l Joint Research: 5 results,  Peer Reviewed: 9 results,  Open Access: 3 results) Presentation (4 results) (of which Int'l Joint Research: 2 results)

  • [Int'l Joint Research] St. Jude Children’s Research Hospital(米国)

    • Related Report
      2018 Research-status Report
  • [Int'l Joint Research] St. Jude Children’s Research Hospital(米国)

    • Related Report
      2017 Research-status Report
  • [Journal Article] Nationwide survey of pediatric hypodiploid acute lymphoblastic leukemia in Japan2019

    • Author(s)
      Ishimaru Sae、Okamoto Yasuhiro、Imai Chihaya、Sakaguchi Hirotoshi、Taki Tomohiko、Hasegawa Daisuke、Cho Yuko、Kakuda Harumi、Sano Hideki、Manabe Atsushi、Imamura Toshihiko、Kato Motohiro、Arakawa Yuki、Shimonodan Hidemi、Sato Atsushi、Suenobu Souichi、et al.
    • Journal Title

      Pediatrics International

      Volume: 61 Issue: 11 Pages: 1103-1108

    • DOI

      10.1111/ped.14006

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Clinical and molecular characteristics of MEF2D fusion-positive B-cell precursor acute lymphoblastic leukemia in childhood, including a novel translocation resulting in MEF2D-HNRNPH1 gene fusion.2019

    • Author(s)
      Ohki K, Kiyokawa N, Hayashi Y, Koh K, Manabe A, Ohara A; Tokyo Children’s Cancer Study Group (TCCSG) et al.
    • Journal Title

      Haematologica.

      Volume: 104(1) Issue: 1 Pages: 128-137

    • DOI

      10.3324/haematol.2017.186320

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Treatment and biology of pediatric acute lymphoblastic leukemia2018

    • Author(s)
      Kato M, Manabe A.
    • Journal Title

      Pediatrics International

      Volume: 60 Issue: 1 Pages: 4-12

    • DOI

      10.1111/ped.13457

    • Related Report
      2018 Research-status Report
    • Peer Reviewed
  • [Journal Article] Regional evaluation of childhood acute lymphoblastic leukemia genetic susceptibility loci among Japanese2018

    • Author(s)
      Urayama Kevin Y.、Takagi Masatoshi、Kawaguchi Takahisa、Matsuo Keitaro、Tanaka Yoichi、Ayukawa Yoko、Arakawa Yuki、Hasegawa Daisuke、Yuza Yuki、Kaneko Takashi、Noguchi Yasushi、Taneyama Yuichi、Ota Setsuo、Inukai Takeshi、Yanagimachi Masakatsu、Keino Dai、Koike Kazutoshi、Toyama Daisuke、Inazawa Johji 他16名
    • Journal Title

      Scientific Reports

      Volume: 8 Issue: 1 Pages: 789-789

    • DOI

      10.1038/s41598-017-19127-7

    • Related Report
      2018 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Preclinical evaluation ofNUDT15-guided thiopurine therapy and its effects on toxicity and anti-leukemic efficacy2018

    • Author(s)
      Nishii R、Moriyama T、Janke LJ、Yang W、Suiter C、Lin TN、Li L、Kihira K、Toyoda H、Hofmann U、Schwab M、Takagi M、Morio T、Manabe A、Kham S、Jiang N、Rabin KR.、Kato M、Koh K、Yeoh AE、Hori H、Yang JJ.
    • Journal Title

      Blood

      Volume: 印刷中 Issue: 22 Pages: 2466-2474

    • DOI

      10.1182/blood-2017-11-815506

    • Related Report
      2018 Research-status Report 2017 Research-status Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] Diplotype analysis of NUDT15 variants and 6-mercaptopurine sensitivity in pediatric lymphoid neoplasms2018

    • Author(s)
      Tsujimoto S, Osumi T, Uchiyama M, Shirai R, Moriyama T, Nishii R, Yamada Y, Kudo K, Sekiguchi M, Arakawa Y, Yoshida M, Uchiyama T, Terui K, Ito S, Koh K, Takita J, Ito E, Tomizawa D, Manabe A, Kiyokawa N, Yang JJ, Kato M.
    • Journal Title

      Leukemia

      Volume: 32 Issue: 12 Pages: 2710-2714

    • DOI

      10.1038/s41375-018-0190-1

    • Related Report
      2018 Research-status Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] Interaction between NUDT15 and ABCC4 variants enhances intolerability of 6-mercaptopurine in Japanese patients with childhood acute lymphoblastic leukemia2018

    • Author(s)
      Tanaka Y, Nakadate H, Kondoh K, Nakamura K, Koh K, Manabe A
    • Journal Title

      The Pharmacogenomics Journal

      Volume: 18 Issue: 2 Pages: 275-280

    • DOI

      10.1038/tpj.2017.12

    • Related Report
      2018 Research-status Report 2017 Research-status Report
    • Peer Reviewed
  • [Journal Article] Diplotype analysis of NUDT15 variants and 6-mercaptopurine sensitivity in Pediatric lymphoid neoplasms2018

    • Author(s)
      Tsujimoto S, Osumi T, Uchiyama M, Shirai R, Moriyama T, Nishii R, Yamada Y, Kudo K, Sekiguchi M, Arakawa Y, Yoshida M, Uchiyama T, Terui K, Ito S, Koh K, Takita J, Ito E, Tomizawa D, Manabe A, Kiyokawa N, Yang JJ, Kato M
    • Journal Title

      Leukemia

      Volume: 印刷中

    • Related Report
      2017 Research-status Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] The effects of inherited NUDT15 polymorphisms on thiopurine active metabolites in Japanese children with acute lymphoblastic leukemia2017

    • Author(s)
      Moriyama Takaya、Nishii Rina、Lin Ting-Nien、Kihira Kentaro、Toyoda Hidemi、Jacob Nersting、Kato Motohiro、Koh Katsuyoshi、Inaba Hiroto、Manabe Atsushi、Schmiegelow Kjeld、Yang Jun J.、Hori Hiroki
    • Journal Title

      Pharmacogenetics and Genomics

      Volume: 27 Issue: 6 Pages: 236-239

    • DOI

      10.1097/fpc.0000000000000282

    • Related Report
      2017 Research-status Report
    • Peer Reviewed / Int'l Joint Research
  • [Presentation] NUDT15 genetic variation is the strongest predictive marker of tolerance to 6-mercaptopurine in Japanese childhood ALL patients: A genome-wide association study.2019

    • Author(s)
      Tanaka Y, Urayama K, Mori M, Hasegawa D, Noguchi Y, Yanagimachi M, Keino D, Ota S, Akabane K, Hangai M, Kawaguchi T, Takagi M, Koh K, Matsuda F, Manabe A.
    • Organizer
      アメリカ血液学会(ASH)
    • Related Report
      2019 Annual Research Report
    • Int'l Joint Research
  • [Presentation] 1.小児ALLにおける高用量メトトレキサート療法時の薬物クリアランスへ影響を及ぼす因子の検討2018

    • Author(s)
      田中庸一、康 勝好、真部 淳
    • Organizer
      第80回日本血液学会学術集会
    • Related Report
      2018 Research-status Report
  • [Presentation] 患者の年齢と肥満度の6-メルカプトプリン投与量への影響2018

    • Author(s)
      田中庸一、康 勝好、真部 淳
    • Organizer
      第60回日本小児血液・がん学会学術集会
    • Related Report
      2018 Research-status Report
  • [Presentation] 3.Tolerable dose of 6-mercaptopurine and prognostic impact of NUDT15-deficient genotype in childhood acute lymphoblastic leukemia2018

    • Author(s)
      Tanaka Y, Kato M, Arakawa Y, Hasegawa D, Fujimura J, Keino D, Sato A, Ueda T, Taneyama Y, Takagi M, Yamamoto M, Matsuoka M, Hino M, Hori H, Koh K, Moriyama T, Yeoh A, Yang JJ, Manabe A.
    • Organizer
      60th ASH Annual Meeting & Exposition
    • Related Report
      2018 Research-status Report
    • Int'l Joint Research

URL: 

Published: 2017-04-28   Modified: 2021-02-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi